Ultragenyx Pharmaceutical Inc. (RARE)
Pharmaceutical Preparations
Latest Price
$13.07
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.09
P/B Ratio
140.09
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 10.65M | $355.0M | 10.81% | +3.35M | 2026-06-30 |
| RTW INVESTMENTS, LP | 7.80M | $260.0M | 7.91% | +4.15M | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6.79M | $226.0M | 6.89% | +1.40M | 2026-06-30 |
| AQR CAPITAL MANAGEMENT LLC | 6.56M | $214.0M | 6.65% | +1.98M | 2026-06-30 |
| STATE STREET CORP | 6.16M | $205.0M | 6.25% | +1.14M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.30M | $143.0M | 4.36% | +106.7K | 2026-06-30 |
| TWO SIGMA INVESTMENTS, LP | 3.62M | $120.0M | 3.67% | -- | 2026-06-30 |
| SANDS CAPITAL MANAGEMENT, LLC | 3.16M | $105.0M | 3.20% | -56.2K | 2026-06-30 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2.94M | $98.0M | 2.98% | +1.51M | 2026-06-30 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 2.85M | $95.0M | 2.89% | +656.8K | 2026-06-30 |